Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 208
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT01588470 | Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM) | ||
| NCT01888237 | High Dose PPI Triple Therapy Versus Sequential Therapy for Helicobacter Pylori Eradication | ||
| NCT00402012 | "TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DM | ||
| NCT00806962 | Phase 1 Norwalk Vaccine Study | ||
| NCT03708211 | A Study to Assess the Relative Bioavailability, Effect of Food, and Gastric Potential Hydrogen (pH) Modification on the Pharmacokinetics (PK) of TAK-931 in Participants With Advanced Solid Tumors | ||
| NCT01577758 | Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C | ||
| NCT07240168 | CurQD as Add-On Therapy in Vedolizumab-Treated Ulcerative Colitis Patients: Retrospective Cohort Study | ||
| NCT02367352 | Alisertib (MLN8237) in Combination With Weekly Paclitaxel in East Asian Patients With Advanced Solid Tumors | ||
| NCT01899053 | A Safety and Pharmacokinetic Study of TAK-228 in Combination With TAK-117 in Adult Participants With Advanced Nonhematologic Malignancies | ||
| NCT01512758 | A Study of Alisertib (MLN8237) in Adult East Asian Participants With Advanced Solid Tumors or Lymphomas | ||
| NCT00651664 | A Phase I Clinical and Pharmacodynamic Study of MLN8237, A Novel Aurora A Kinase Inhibitor, in Participants With Advanced Malignancies | ||
| NCT00391755 | A Double-Blind Placebo-Controlled Trial of Rozerem in Migraine Headaches | ||
| NCT02056015 | A Phase I Study of MLN6907 in Patients With Metastatic Colorectal | ||
| NCT01425008 | Study of MLN2480 in Participants With Relapsed or Refractory Solid Tumors Followed by a Dose Expansion in Participants With Metastatic Melanoma | ||
| NCT00227110 | Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH) | ||
| NCT03965624 | Efficacy and Safety of Ixazomib and Dexamethasone Refractory Autoimmune Cytopenia | ||
| NCT01158911 | Uric Acid and Long-term Outcomes in Chronic Kidney Disease | ||
| NCT01990534 | A Study of Brentuximab Vedotin in Participants With Relapsed or Refractory Hodgkin Lymphoma | ||
| NCT00337272 | Treating Chronic Insomnia in Breast Cancer Patients | ||
| NCT01850524 | IXAZOMIB Plus Lenalidomide and Dexamethasone Versus Placebo Plus Lenalidomide and Dexamethasone in Adult Patients With Newly Diagnosed Multiple Myeloma | ||
| NCT01939899 | Phase 2 Study of Oral IXAZOMIB in Adult Participants With Relapsed and/or Refractory Follicular Lymphoma | ||
| NCT03106597 | Manidipine Versus Amlodipine in Patients With Hypertension | ||
| NCT03657160 | Vedolizumab in the Prophylaxis of Intestinal Acute Graft Versus Host Disease (aGVHD) in Participants Undergoing Allogeneic Hematopoietic Stem Cell (Allo-HSCT) Transplantation | ||
| NCT01167543 | Relationship and Pathophysiology of Gastroesophageal Reflux and Dental/Periodontal Disease | ||
| NCT01351350 | Dose Escalation Study of MLN0128 in Combination With Paclitaxel, With/Without Trastuzumab, in Subjects With Advanced Solid Malignancies | ||
| NCT01449461 | A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Anti-Tumor Activity of the Oral Anaplastic Lymphoma Kinase (ALK)/Epidermal Growth Factor Receptor (EGFR) Inhibitor Brigatinib (AP26113) | ||
| NCT02727959 | Inflammatory Bowel Disease in South Eastern Norway | ||
| NCT01058707 | Dose Escalation Study of MLN0128 in Participants With Advanced Malignancies | ||
| NCT00521742 | Efficacy of Pioglitazone Compared to Glyburide in Treating Subjects With Type 2 Diabetes Mellitus and Mild Cardiac Disease | ||
| NCT00830869 | A Phase 1 Study of IXAZOMIB in Adult Patients With Advanced Nonhematologic Malignancies | ||
| NCT01814826 | Study of MLN4924 Plus Azacitidine in Treatment-naive Participants With Acute Myelogenous Leukemia (AML) Who Are 60 Years or Older | ||
| NCT01328392 | Evaluating Treatment Response in Laryngo-Pharyngeal Reflux | ||
| NCT01862328 | Dose Escalation, Multi-arm Study of MLN4924 Plus Docetaxel, Gemcitabine, or Combination of Carboplatin and Paclitaxel in Participants With Solid Tumors | ||
| NCT02443922 | Dynamic Responsiveness of Insulin Secretory Parameters To Sitagliptin and Glimeperide Administration in Type 2 DM | ||
| NCT00770367 | Pioglitazone and Serum Asymmetric Dimethylarginine (ADMA) in Patients With Diabetes | ||
| NCT04563520 | SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis | ||
| NCT03811834 | A Study to Assess Absolute Bioavailability (ABA) of Mobocertinib (TAK-788) and to Characterize Mass Balance, Pharmacokinetics (PK), Metabolism, and Excretion of Carbon-14 ([14C])-Mobocertinib in Male Healthy Participants | ||
| NCT02246647 | Biomarkers for Intestinal Permeability in Patients With Constipation | ||
| NCT03312894 | Efficacy and Safety of TAK-653 in Treatment-Resistant Depression | ||
| NCT02135445 | Safety and Efficacy of TAK-385 for Patients With Localized Prostate Cancer | ||
| NCT05826756 | Project PEER: Understanding the Lung Cancer Patient ExperiEnce in the Real-World Setting | ||
| NCT00706004 | Short Term Safety and Efficacy of Lubiprostone in Adults With Cystic Fibrosis | ||
| NCT01023620 | HIV Acquired Lipodystrophy (HAL) Classification, Measurement and Fat Response to Thiazolidinedione (TZD) (Pioglitazone) | ||
| NCT03482453 | A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-788 Followed by Evaluation of the Effects of a Low-Fat Meal on TAK-788 PK and Evaluation of Relative Bioavailability of TAK-788 Capsules in Healthy Participants | ||
| NCT01235741 | A Study To Examine The Efficacy And Safety Of Pramlintide+Metreleptin In Obese Subjects | ||
| NCT02412722 | A Safety, Tolerability, and Pharmacokinetics Study of MLN0128 as a Single Agent and in Combination With Paclitaxel in Adults With Advanced Nonhematologic Malignancies | ||
| NCT00645801 | Amitiza® Plus GoLYTELY® (PEG) Versus Placebo Plus GoLYTELY® for Outpatient Colonoscopy Preparation | ||
| NCT02094573 | A Study to Evaluate the Efficacy of Brigatinib (AP26113) in Participants With Anaplastic Lymphoma Kinase (ALK)-Positive, Non-small Cell Lung Cancer (NSCLC) Previously Treated With Crizotinib | ||
| NCT03268941 | A Study to Evaluate the Safety, Pharmacokinetics (PK) and Pharmacodynamics (PD) for TAK-906 in Participants With Diabetes Mellitus and Gastroparesis (DG) or With Idiopathic Gastroparesis (IG) | ||
| NCT02843529 | Evaluation of a Computerized Complex Instrumental Activities of Daily Living Marker (NMI) |
